Market Closed -
Nasdaq Stockholm
08:59:57 05/06/2024 pm IST
5-day change
1st Jan Change
10.9
SEK
+3.81%
+12.14%
-2.85%
Presenter SpeechChristina Rubenhag (Executives)Okay. So let's start. Welcome, everyone, to the...
Boule Diagnostics AB Appoints Rikke Rytter as Director
08/05
CI
Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024
07/05
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
07/05
CI
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
06/02
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
06/02
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
06/02
CI
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
06/02
CI
Transcript : Boule Diagnostics AB, Q3 2023 Earnings Call, Nov 09, 2023
09/11
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
09/11
CI
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
24/23/24
CI
Transcript : Boule Diagnostics AB, Q1 2023 Earnings Call, May 03, 2023
03/23/03
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
03/23/03
CI
Transcript : Boule Diagnostics AB, 2022 Earnings Call, Feb 02, 2023
02/23/02
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
02/23/02
CI
Transcript : Boule Diagnostics AB, Q3 2022 Earnings Call, Nov 10, 2022
10/22/10
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
10/22/10
CI
Boule Diagnostics AB announced that it has received funding from Keel Capital Ab
07/22/07
CI
Transcript : Boule Diagnostics AB, H1 2022 Earnings Call, Jul 18, 2022
18/22/18
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
18/22/18
CI
Transcript : Boule Diagnostics AB, Q1 2022 Earnings Call, May 04, 2022
04/22/04
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022
04/22/04
CI
Transcript : Boule Diagnostics AB, Q4 2021 Earnings Call, Feb 03, 2022
03/22/03
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
03/22/03
CI
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2021
03/22/03
CI
Transcript : Boule Diagnostics AB, Nine Months 2021 Earnings Call, Nov 10, 2021
10/21/10
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Companyâs product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Companyâs primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
More about the company
Last Close Price
10.5
SEK
Average target price
10.9
SEK
Spread / Average Target
+3.81%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1